Efficacy of flupentixol and melitracen combined with pinaverium bromide in irritable bowel syndrome
CHEN Fei;ZHOU Xue-lian;Department of Gastroenterology,Zhuji People's Hospital;
Objective To investigate the efficacy of flupentixol and melitracen combined with pinaverium bromide in the treatment of patients with irritable bowel syndrome. Methods A total of 64 patients with irritable bowel syndrome from October 2014 to October 2015 in department of gastroenterology of Zhuji People's Hospital were collected and randomly divided into two groups,with 32 cases in each group. Patients in control group received with pinaverium bromide by oral,patients in combination group received flupentixol and melitracen by oral on the basis of control group. The gastrointestinal symptom rating scale( GSRS),self-rating anxiety scale( SAS),self-rating depression scale( SDS) score and clinical efficacy pre-and post-treatment were compared between two groups. Results Compared with pre-treatment,the main symptoms score in two groups decreased significantly( P 0. 05); compared with control group,the main symptoms score in combination group decreased significantly( P 0. 05). Compared with pretreatment,the SAS and SDS scores decreased significantly( P 0. 05); compared with control group,the SAS and SDS scores in combination group decreased significantly( P 0. 05). There was no significant difference in total efficacy between control group and combination group( 93. 75%vs. 81. 25%,χ2= 1. 237,P = 0. 266). There was no adverse event in two groups during treatment. Conclusion Flupentixol and melitracen combined with pinaverium bromide could significantly improve the anxiety and depression in the treatment of irritable bowel syndrome,which could promote the recovery of gastrointestinal function.
【CateGory Index】： R574.4